Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

Abstract Background There are inconsistencies in the literature regarding the prevalence and assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored CIPN natural history and its characteristics in patients receiving taxane- and platinum-based chemotherapy. Patients and m...

Full description

Bibliographic Details
Main Authors: Alex Molassiotis, Hui Lin Cheng, Violeta Lopez, Joseph S. K. Au, Alexandre Chan, Aishwarya Bandla, K. T. Leung, Y. C. Li, K. H. Wong, Lorna K. P. Suen, Choi Wan Chan, Janelle Yorke, Carole Farrell, Raghav Sundar
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Cancer
Subjects:
Peripheral neuropathy
Neurotoxicity
Chemotherapy
Cancer
Assessment
Taxanes
Online Access:http://link.springer.com/article/10.1186/s12885-019-5302-4

Internet

http://link.springer.com/article/10.1186/s12885-019-5302-4

Similar Items